Deutsch English Français

Contact

EP0970067

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...

Extract from the Register of European Patents

EP About this file: EP0970067

EP0970067 - (METHYLSULFONYL)PHENYL-2-(5H)-FURANONES WITH OXYGEN LINK AS COX-2 INHIBITORS [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 07.05.2004 Database last updated on 10.05.2025
Most recent event Tooltip	05.06.2009	Change - representative	published on 08.07.2009 [2009/28]
Applicant(s)	For all designated states Merck Frosst Canada & Co. 16711 Trans-Canada Highway Kirkland, Quebec H9H 3L1 / CA
	[N/P]
Former [2000/02]	For all designated states Merck Frosst Canada & Co. 16711 Trans Canada Highway Kirkland, Quebec H9H 3L1 / CA
Inventor(s)	01 / LEBLANC, Yves 16711 Trans Canada Highway Kirkland, Quebec H9H 3L1 / CA
	02 / ROY, Patrick 16711 Trans Canada Highway Kirkland, Quebc H9H 3L1 / CA
	03 / LEGER, Serge 16711 Trans Canada Highway Kirkland, Quebec H9H 3L1 / CA
	04 / GRIMM, Erich 16711 Trans Canada Highway Kirkland, Quebec H9H 3L1 / CA
	05 / WANG, Zhaoyin 16711 Trans Canada Highway Kirkland, Quebec H9H 3L1 / CA
	[2000/02]
Representative(s)	Horgan, James Michael Frederic, et al Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road, Harlow Essex CM20 2QR / GB
	[N/P]
Former [2009/28]	Horgan, James Michael Frederic, et al Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road Harlow Essex CM20 2QR / GB
Former [2000/02]	Horgan, James Michael Frederic, et al Merck & Co., Inc., Terlings Park, Eastwick Road Harlow, Essex CM20 2QR / GB
Application number, filing date	98912164.5	12.03.1998
	[2000/02]
	WO1998CA00225
Priority number, date	US19970040794P	14.03.1997 Original published format: US 40794 P
	GB19970007488	14.04.1997 Original published format: GB 9707488
	[2000/02]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9841516
	Date:	24.09.1998
	Language:	EN
	[1998/38]
	Type:	A1 Application with search report
	No.:	EP0970067
	Date:	12.01.2000
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 24.09.1998 takes the place of the publication of the European patent application.
	[2000/02]
	Type:	B1 Patent specification
	No.:	EP0970067
	Date:	02.07.2003
	Language:	EN
	[2003/27]
Search report(s)	International search report - published on:	EP	24.09.1998
Classification	IPC:	C07D307/60, C07D407/12, A61K31/34	[2000/02]
	CPC:	C07D407/12 (EP); A61P29/00 (EP); A61P43/00 (EP); C07D307/60 (EP)
Designated contracting states	AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [2000/02]
Title	German:	(METHYLSULFONYL)PHENYL-2-(5H)-FURANONE MIT SAUERSTOFF-BINDUNG ALS COX-2-HEMMER	[2000/02]
	English:	(METHYLSULFONYL)PHENYL-2-(5H)-FURANONES WITH OXYGEN LINK AS COX-2 INHIBITORS	[2000/02]
	French:	(METHYLSUFONYL)PHENYL-2-(5H)-FURANONES A LIAISON OXYGENE, UTILISEES COMME INHIBITEURS DE CYCLO-OXYGENASE-2	[2002/23]
	Former [2000/02]	(METHYLSUFONYL)PHENYL-2-(5H)-FURANONES A LIAISON OXYGENE, UTILISES COMME INHIBITEURS DE CYCLO-OXYGENASE-2
Entry into regional phase	14.10.1999	National basic fee paid
	14.10.1999	Designation fee(s) paid
	14.10.1999	Examination fee paid
Examination procedure	08.10.1998	Request for preliminary examination filed International Preliminary Examining Authority: EP
	14.10.1999	Examination requested [2000/02]
	16.05.2001	Despatch of a communication from the examining division (Time limit: M06)
	22.11.2001	Reply to a communication from the examining division
	23.01.2002	Despatch of communication that the application is refused, reason: substantive examination {1}
	27.06.2002	Despatch of communication of intention to grant (Approval: Yes)
	30.09.2002	Communication of intention to grant the patent
	10.01.2003	Fee for grant paid
	10.01.2003	Fee for publishing/printing paid
Appeal following examination	14.03.2002	Appeal received
Opposition(s)	05.04.2004	No opposition filed within time limit [2004/26]
Fees paid	Renewal fee
	31.03.2000	Renewal fee patent year 03
	02.04.2001	Renewal fee patent year 04
	02.04.2002	Renewal fee patent year 05
	05.03.2003	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AT	02.07.2003
	BE	02.07.2003
	CH	02.07.2003
	FI	02.07.2003
	LI	02.07.2003
	NL	02.07.2003
	DK	02.10.2003
	GR	02.10.2003
	PT	02.10.2003
	SE	02.10.2003
	IE	12.03.2004
	LU	12.03.2004
	[2005/24]
Former [2005/23]	AT	02.07.2003
	BE	02.07.2003
	CH	02.07.2003
	FI	02.07.2003
	LI	02.07.2003
	NL	02.07.2003
	DK	02.10.2003
	GR	02.10.2003
	PT	02.10.2003
	SE	02.10.2003
	LU	12.03.2004
Former [2004/29]	AT	02.07.2003
	BE	02.07.2003
	CH	02.07.2003
	FI	02.07.2003
	LI	02.07.2003
	NL	02.07.2003
	DK	02.10.2003
	GR	02.10.2003
	PT	02.10.2003
	SE	02.10.2003
Former [2004/28]	AT	02.07.2003
	BE	02.07.2003
	CH	02.07.2003
	FI	02.07.2003
	LI	02.07.2003
	NL	02.07.2003
	GR	02.10.2003
	PT	02.10.2003
	SE	02.10.2003
Former [2004/22]	AT	02.07.2003
	CH	02.07.2003
	FI	02.07.2003
	LI	02.07.2003
	NL	02.07.2003
	GR	02.10.2003
	PT	02.10.2003
	SE	02.10.2003
Former [2004/16]	AT	02.07.2003
	FI	02.07.2003
	NL	02.07.2003
	GR	02.10.2003
	PT	02.10.2003
	SE	02.10.2003
Former [2004/14]	AT	02.07.2003
	FI	02.07.2003
	NL	02.07.2003
	GR	02.10.2003
	PT	02.10.2003
Former [2004/13]	FI	02.07.2003
	NL	02.07.2003
	PT	02.10.2003
Former [2004/12]	FI	02.07.2003
	NL	02.07.2003
Former [2004/10]	NL	02.07.2003
Cited in	International search	[A]JPH0551385 ;
		[Y]WO9608482 (MERCK & CO INC [US], et al) [Y] 1,3,9,10,13-15 * page 1, line 6 - page 2, line 8 * * see page 3, formula I and definition of substituents *;
		[Y]WO9619469 (MERCK FROSST CANADA INC [CA], et al) [Y] 1,3,9,10,13-15 * claims 1-5,20,21,25-29; table - *;
		[A]EP0754687 (MERCK FROSST CANADA INC [CA]) [A] 1-7,9,10,13-15 * claims 1,17,27-33; table - *;
		[PX]WO9714691 (MERCK FROSST CANADA INC [CA], et al) [PX] 1-3,9,10,13-15 * see page 111, example 134; page 112, examples 140, 141, 143, 144; page 113, examples 146-149; page 117, examples 173, 174; page 118, examples 177-179; * * page 122, example 206; page 123, examples 207, 208 * * claims 1,17,18,29,30,35-39 *;
		[PX]WO9716435 (MERCK FROSST CANADA INC [CA], et al) [PX] 1-3 * see page 34, example 39 *;
		[PX]WO9728121 (MERCK FROSST CANADA INC [CA], et al) [PX] 1-3 * see page 31, compound 7 *;
		[PX]WO9745420 (MERCK & CO INC [US], et al) [PX] 1-3,9,10,13-15 * abstract * * page 1, line 6 - page 2, line 8 * * page 3, line 2 - line 18 * * see page 29, compound Ia *
		[A] - PATENT ABSTRACTS OF JAPAN, (19930708), vol. 17, no. 361, Database accession no. (C - 1080), & JP05051385 A 19930302 (SANKYO CO LTD) [A] 1 * see formula II *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.32; 34p